ConductScience.org, home

Paper33575950

Pharmacokinetics and Pharmacodynamics of Esomeprazole/Sodium Bicarbonate Immediate-Release Capsules in Healthy Chinese Volunteers: A Cross-Over, Randomized Controlled Trial.

Jing S and 7 others. Adv Ther, 2021. Cited by 4 papers, by iCite.

Cite this record

ConductScience Library. Pharmacokinetics and Pharmacodynamics of Esomeprazole/Sodium Bicarbonate Immediate-Release Capsules in Healthy Chinese Volunteers: A Cross-Over, Randomized Controlled Trial. Papers, record 33575950. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/33575950

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Pharmacokinetics and Pharmacodynamics of Esomeprazole/Sodium Bicarbonate Immediate-Release Capsules in Healthy Chinese Volunteers: A Cross-Over, Randomized Controlled Trial.
PubMed
Journal
Adv Ther
PubMed
Year
2021
PubMed
Publication types
Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
4
iCite
Relative citation ratio, by iCite
0.4
iCite
Revised in PubMed
2022-05-31
PubMed

Authors8

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Jing SShan
2Zhu YYue
3Liu WWenfang
4Yang KKexu
5Hu LLili
6Deng DDan
7Lu CChunyan
8Lin YYang

Source PubMed

Download CSV of authors

Topics9

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
EsomeprazoleMajor topic
Proton Pump InhibitorsMajor topic
Sodium BicarbonateMajor topic
Bicarbonates
Capsules
China
Cross-Over Studies
Healthy Volunteers
Humans

Source PubMed

Download CSV of topics

References40

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
128780072Presentation and Epidemiology of Gastroesophageal Reflux Disease.Gastroenterology2018https://conductscience.org/library/papers/28780072PubMed
228242110Peptic ulcer disease.Lancet2017https://conductscience.org/library/papers/28242110PubMed
32784036425 Years of Proton Pump Inhibitors: A Comprehensive Review.Gut Liver2017https://conductscience.org/library/papers/27840364PubMed
427206157Gastroesophageal reflux disease-related and functional heartburn: pathophysiology and treatment.Curr Opin Gastroenterol2016https://conductscience.org/library/papers/27206157PubMed
526629969An Evidence-Based Approach to the Treatment of Gastroesophageal Reflux Disease.JAMA Surg2016https://conductscience.org/library/papers/26629969PubMed
626661629Esomeprazole induced galactorrhea: a novel side effect.Clin J Gastroenterol2016https://conductscience.org/library/papers/26661629PubMed
726970404Pharmacokinetic and Pharmacodynamic Modeling Analysis of Intravenous Esomeprazole in Healthy Volunteers.J Clin Pharmacol2016https://conductscience.org/library/papers/26970404PubMed
828930292Proton-pump inhibitors: understanding the complications and risks.Nat Rev Gastroenterol Hepatol2017https://conductscience.org/library/papers/28930292PubMed
929620484Proton pump inhibitors: from CYP2C19 pharmacogenetics to precision medicine.Expert Opin Drug Metab Toxicol2018https://conductscience.org/library/papers/29620484PubMed
1025473155CYP2C19 polymorphism influences Helicobacter pylori eradication.World J Gastroenterol2014https://conductscience.org/library/papers/25473155PubMed
1125974703Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2D6 and CYP2C19 Genotypes and Dosing of Selective Serotonin Reuptake Inhibitors.Clin Pharmacol Ther2015https://conductscience.org/library/papers/25974703PubMed
1229311135Clinical Pharmacokinetics and the Impact of Genetic Polymorphism on a CYP2C19 Substrate, BMS-823778, in Healthy Subjects.Drug Metab Dispos2018https://conductscience.org/library/papers/29311135PubMed
1331006731Association of CYP2C19 Polymorphisms With Clopidogrel Reactivity and Clinical Outcomes in Chronic Ischemic Stroke.Circ J2019https://conductscience.org/library/papers/31006731PubMed
1424440142Impact of CYP2C19 polymorphism and proton pump inhibitors on platelet reactivity to clopidogrel and clinical outcomes following stent implantation.Thromb Res2014https://conductscience.org/library/papers/24440142PubMed
1518958459Impact of CYP2C19 polymorphisms on the clinical action of proton pump inhibitors (PPIs).Eur J Clin Pharmacol2009https://conductscience.org/library/papers/18958459PubMed
1625469781Enteric coating can lead to reduced antiplatelet effect of low-dose acetylsalicylic acid.Basic Clin Pharmacol Toxicol2015https://conductscience.org/library/papers/25469781PubMed
1716259581Review of immediate-release omeprazole for the treatment of gastric acid-related disorders.Expert Opin Pharmacother2005https://conductscience.org/library/papers/16259581PubMed
1825706883Challenges of correlating pH change with relief of clinical symptoms in gastro esophageal reflux disease: a phase III, randomized study of Zegerid versus Losec.PLoS One2015https://conductscience.org/library/papers/25706883PubMed
1923821352International guidelines for bioequivalence of systemically available orally administered generic drug products: a survey of similarities and differences.AAPS J2013https://conductscience.org/library/papers/23821352PubMed
2024218038Futility rules in bioequivalence trials with sequential designs.AAPS J2014https://conductscience.org/library/papers/24218038PubMed

See all 40 referencesDownload CSV of references

Cited by3

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 4 citations.

PMIDTitleJournalYearIn PapersSource
36814893Development of a Fast Onset Proton Pump Inhibitor: Comparison of Fixed-Dose Combination of Rabeprazole and Sodium Bicarbonate (YPI-011) to the Conventional Enteric-Coated Rabeprazole.Drug Des Devel Ther2023https://conductscience.org/library/papers/36814893PubMed
36670124Pharmacokinetics and bioequivalence evaluation of omeprazole and sodium bicarbonate dry suspensions in healthy Chinese volunteers.Sci Rep2023https://conductscience.org/library/papers/36670124PubMed
34992346Comparative Pharmacokinetics/Pharmacodynamics of Fixed-Dose Combination of Esomeprazole and Calcium Carbonate (AD-206) to the Conventional Esomeprazole.Drug Des Devel Ther2021https://conductscience.org/library/papers/34992346PubMed

Download CSV of cited by

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
CYP2C191557PubTator's text mininghttps://conductscience.org/library/genes/1557

Source NCBI Gene

Download CSV of genes

Data1

The data bank entries PubMed's record names. Trial numbers are under Trials.

Data bankAccession
ChiCTRChiCTR1900024935

Source PubMed

Download CSV of data

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/33575950

GET https://conductscience.org/api/papers/v1/33575950/references?page=2